Transcriptional control of regulatory T-cell differentiation

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 78, Issue 1, 2013, Pages 215-222

  Van Der Veeken, Joris ^a   Arvey, Aaron ^a   Rudensky, Alexander ^a,b,c  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b Immunology Program   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR FOXP3; CHROMATIN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL MATURATION; EPIGENETICS; GENE CONTROL; HUMAN; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN STABILITY; REGULATORY T LYMPHOCYTE; STABLE EXPRESSION; ANIMAL; CELL DIFFERENTIATION; CELL LINEAGE; CELL MEMBRANE; CHROMATIN; CYTOLOGY; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETIC TRANSCRIPTION; INFLAMMATION; METABOLISM; MOUSE; PHENOTYPE;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; CELL MEMBRANE; CHROMATIN; EPIGENESIS, GENETIC; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; MICE; PHENOTYPE; PROMOTER REGIONS, GENETIC; T-LYMPHOCYTES, REGULATORY; TRANSCRIPTION, GENETIC;

EID: 84904913966     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.2013.78.020289     Document Type: Article

References (69)

1. Allan SE, Crome SQ, Crellin NK, Passerini L, Steiner TS, Bacchetta R, Roncarolo MG, Levings MK. 2007. Activationinduced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 19: 345-354.
2. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, Kelly TE, Saulsbury FT, Chance PF, Ochs HD. 2001. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27: 20-21.
3. Benson MJ, Pino-Lagos K, Rosemblatt M, Noelle RJ. 2007. Alltrans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of costimulation. J Exp Med 204: 1765-1774.
4. Bettini ML, Pan F, Bettini M, Finkelstein D, Rehg JE, Floess S, Bell BD, Ziegler SF, Huehn J, Pardoll DM, et al. 2012. Loss of epigenetic modification driven by the Foxp3 transcription factor leads to regulatory T cell insufficiency. Immunity 36:717-730.
5. Beyer M, Thabet Y, Muller RU, Sadlon T, Classen S, Lahl K, Basu S, Zhou X, Bailey-Bucktrout SL, Krebs W, et al. 2011. Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiation. Nat Immunol 12: 898-907.
6. Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA,Wilkinson JE, Galas D, Ziegler SF, Ramsdell F. 2001. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 27: 68-73.
7. Buckner JH. 2010. Mechanisms of impaired regulation by CD4({thorn})CD25({thorn})FOXP3({thorn}) regulatory T cells in human autoimmune diseases. Nat Rev Immunol 10: 849-859.
8. Burchill MA, Yang J, Vogtenhuber C, Blazar BR, Farrar MA. 2007. IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3{thorn} regulatory T cells. J Immunol 178: 280-290.
9. Chatila TA, Blaeser F, Ho N, Lederman HM, Voulgaropoulos C, Helms C, Bowcock AM. 2000. JM2, encoding a fork headrelated protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest 106: R75-R81.
10. Chaudhry A, Rudensky AY. 2013. Control of inflammation by integration of environmental cues by regulatory T cells. J Clin Invest 123: 939-944.
11. ChenQ,KimYC,Laurence A,PunkosdyGA,ShevachEM. 2011. IL-2 controls the stability of Foxp3 expression in TGF-betainduced Foxp3{thorn} T cells in vivo. J Immunol 186: 6329-6337.
12. Ciofani M, Madar A, Galan C, Sellars M, Mace K, Pauli F, Agarwal A, Huang W, Parkurst CN, Muratet M, et al. 2012. A validated regulatory network for Th17 cell specification. Cell 151: 289-303.
13. Darce J, Rudra D, Li L, Nishio J, Cipolletta D, Rudensky AY, Mathis D, Benoist C. 2012. An N-terminal mutation of the Foxp3 transcription factor alleviates arthritis but exacerbates diabetes. Immunity 36: 731-741.
14. De Laat W, Duboule D. 2013. Topology of mammalian developmental enhancers and their regulatory landscapes. Nature 502: 499-506.
15. Fontenot JD, Gavin MA, Rudensky AY. 2003. Foxp3 programs the development and function of CD4{thorn}CD25{thorn} regulatory T cells. Nat Immunol 4: 330-336.
16. Fontenot JD, Dooley JL, Farr AG, Rudensky AY. 2005a. Developmental regulation of Foxp3 expression during ontogeny. J Exp Med 202: 901-906.
17. Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY. 2005b. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 6: 1142-1151.
18. Gavin MA, Torgerson TR, Houston E, DeRoos P, HoWY, Stray-Pedersen A, Ocheltree EL, Greenberg PD, Ochs HD, Rudensky AY. 2006. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci 103: 6659-6664.
19. Gavin MA, Rasmussen JP, Fontenot JD, Vasta V, Manganiello VC, Beavo JA, Rudensky AY. 2007. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445:771-775.
20. Ghisletti S, Barozzi I, Mietton F, Polletti S, De Santa F, Venturini E, Gregory L, Lonie L, Chew A, Wei CL, et al. 2010. Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. Immunity 32: 317-328.
21. Glasmacher E, Agrawal S, Chang AB, Murphy TL, Zeng W, Vander Lugt B, Khan AA, Ciofani M, Spooner CJ, Rutz S, et al. 2012. A genomic regulatory element that directs assembly and function of immune-specific AP-1-IRF complexes. Science 338: 975-980.
22. Gottschalk RA, Corse E, Allison JP. 2010. TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo. J Exp Med 207: 1701-1711.
23. Harada Y, Elly C, Ying G, Paik JH, DePinho RA, Liu YC. 2010. Transcription factors Foxo3a and Foxo1 couple the E3 ligase Cbl-b to the induction of Foxp3 expression in induced regulatory T cells. J Exp Med 207: 1381-1391.
24. Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, Cheng JX, Murre C, Singh H, Glass CK. 2010. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 38: 576-589.
25. Hill JA, Feuerer M, Tash K, Haxhinasto S, Perez J, Melamed R, Mathis D, Benoist C. 2007. Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity 27: 786-800.
26. Hori S, Nomura T, Sakaguchi S. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061.
27. Josefowicz SZ, Lu LF, Rudensky AY. 2012a. Regulatory T cells:Mechanisms of differentiation and function. Annu Rev Immunol 30: 531-564.
28. Josefowicz SZ, Niec RE, Kim HY, Treuting P, Chinen T, Zheng Y, Umetsu DT, Rudensky AY. 2012b. Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature 482: 395-399.
29. Khattri R, Cox T, Yasayko SA, Ramsdell F. 2003. An essential role for Scurfin in CD4{thorn}CD25{thorn} T regulatory cells. Nat Immunol 4: 337-342.
30. Kim JM, Rasmussen JP, Rudensky AY. 2007. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 8: 191-197.
31. Koch MA, Tucker-Heard G, Perdue NR, Killebrew JR, Urdahl KB, Campbell DJ. 2009. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol 10: 595-602.
32. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, von Boehmer H. 2005. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 6: 1219-1227.
33. Lee HM, Bautista JL, Scott-Browne J, Mohan JF, Hsieh CS. 2012. A broad range of self-reactivity drives thymic regulatory T cell selection to limit responses to self. Immunity 37:475-486.
34. Li P, Spolski R, Liao W, Wang L, Murphy TL, Murphy KM, Leonard WJ. 2012. BATF-JUN is critical for IRF4-mediated transcription in T cells. Nature 490: 543-546.
35. Lin W, Haribhai D, Relland LM, Truong N, Carlson MR, Williams CB, Chatila TA. 2007. Regulatory T cell development in the absence of functional Foxp3. Nat Immunol 8: 359-368.
36. Marson A, Kretschmer K, Frampton GM, Jacobsen ES, Polansky JK, MacIsaac KD, Levine SS, Fraenkel E, von Boehmer H, Young RA. 2007. Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 445: 931-935.
37. Mercer EM, Lin YC, Benner C, Jhunjhunwala S, Dutkowski J, Flores M, Sigvardsson M, Ideker T, Glass CK, Murre C. 2011. Multilineage priming of enhancer repertoires precedes commitment to the B and myeloid cell lineages in hematopoietic progenitors. Immunity 35: 413-425.
38. Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, Niwa A, Parizot C, Taflin C, Heike T, Valeyre D, et al. 2009. Functional delineation and differentiation dynamics of human CD4{thorn} T cells expressing the FoxP3 transcription factor. Immunity 30: 899-911.
39. Miyao T, Floess S, Setoguchi R, Luche H, Fehling HJ, Waldmann H, Huehn J, Hori S. 2012. Plasticity of Foxp3({thorn}) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells. Immunity 36: 262-275.
40. Moran AE, Holzapfel KL, Xing Y, Cunningham NR, Maltzman JS, Punt J, Hogquist KA. 2011. T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse. J Exp Med 208: 1279-1289.
41. Mouly E, Chemin K, Nguyen HV, Chopin M, Mesnard L, Leitede-Moraes M, Burlen-defranoux O, Bandeira A, Bories JC. 2010. The Ets-1 transcription factor controls the development and function of natural regulatory T cells. J Exp Med 207:2113-2125.
42. Nagar M, Vernitsky H, Cohen Y, Dominissini D, Berkun Y, Rechavi G, Amariglio N, Goldstein I. 2008. Epigenetic inheritance of DNA methylation limits activation-induced expression of FOXP3 in conventional human CD25-CD4{thorn} T cells. Int Immunol 20: 1041-1055.
43. Ohkura N, Hamaguchi M, Morikawa H, Sugimura K, Tanaka A, Ito Y, Osaki M, Tanaka Y, Yamashita R, Nakano N, et al. 2012. T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development. Immunity 37:785-799.
44. Ouyang W, Beckett O, Ma Q, Paik JH, DePinho RA, Li MO. 2010. Foxo proteins cooperatively control the differentiation of Foxp3{thorn} regulatory T cells. Nat Immunol 11: 618-627.
45. Pandiyan P, Zheng L, Ishihara S, Reed J, Lenardo MJ. 2007. CD4{thorn}CD25{thorn}Foxp3{thorn} regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4{thorn} T cells. Nat Immunol 8: 1353-1362.
46. Polansky JK, Kretschmer K, Freyer J, Floess S, Garbe A, Baron U, Olek S, Hamann A, von Boehmer H, Huehn J. 2008. DNA methylation controls Foxp3 gene expression. Eur J Immunol 38: 1654-1663.
47. Ruan Q, Kameswaran V, Tone Y, Li L, Liou HC, Greene MI, Tone M, Chen YH. 2009. Development of Foxp3({thorn}) regulatory t cells is driven by the c-Rel enhanceosome. Immunity 31:932-940.
48. Rubtsov YP, Niec RE, Josefowicz S, Li L, Darce J, Mathis D, Benoist C, Rudensky AY. 2010. Stability of the regulatory T cell lineage in vivo. Science 329: 1667-1671.
49. Rudra D, Egawa T, Chong MM, Treuting P, Littman DR, Rudensky AY. 2009. Runx-CBFbeta complexes control expression of the transcription factor Foxp3 in regulatory T cells. Nat Immunol 10: 1170-1177.
50. Rudra D, deRoos P, Chaudhry A, Niec RE, Arvey A, Samstein RM, Leslie C, Shaffer SA, Goodlett DR, Rudensky AY. 2012. Transcription factor Foxp3 and its protein partners form a complex regulatory network. Nat Immunol 13: 1010-1019.
51. Samstein RM, Arvey A, Josefowicz SZ, Peng X, Reynolds A, Sandstrom R, Neph S, Sabo P, Kim JM, Liao W, et al. 2012a. Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification. Cell 151: 153-166.
52. Samstein RM, Josefowicz SZ, Arvey A, Treuting PM, Rudensky AY. 2012b. Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict. Cell 150: 29-38.
53. Schlenner SM,Weigmann B, Ruan Q, Chen Y, von Boehmer H. 2012. Smad3 binding to the foxp3 enhancer is dispensable for the development of regulatory T cells with the exception of the gut. J Exp Med 209: 1529-1535.
54. Schubert LA, Jeffery E, Zhang Y, Ramsdell F, Ziegler SF. 2001. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J Biol Chem 276: 37672-37679.
55. Schuster M, Glauben R, Plaza-Sirvent C, Schreiber L, Annemann M, Floess S, Kuhl AA, Clayton LK, Sparwasser T, Schulze-Osthoff K, et al. 2012. IkB(NS) protein mediates regulatory T cell development via induction of the Foxp3 transcription factor. Immunity 37: 998-1008.
56. Sekiya T, Kashiwagi I, Yoshida R, Fukaya T, Morita R, Kimura A, Ichinose H, Metzger D, Chambon P, Yoshimura A. 2013. Nr4a receptors are essential for thymic regulatory T cell development and immune homeostasis. Nat Immunol 14:230-237.
57. Tai X, Erman B, Alag A, Mu J, Kimura M, Katz G, Guinter T, McCaughtry T, Etzensperger R, Feigenbaum L, et al. 2013. Foxp3 transcription factor is proapoptotic and lethal to developing regulatory T cells unless counterbalanced by cytokine survival signals. Immunity 38: 1116-1128.
58. Toker A, Engelbert D, Garg G, Polansky JK, Floess S, Miyao T, Baron U, Duber S, Geffers R, Giehr P, et al. 2013. Active demethylation of the Foxp3 locus leads to the generation of stable regulatory T cells within the thymus. J Immunol 190:3180-3188.
59. Tone Y, Furuuchi K, Kojima Y, Tykocinski ML, Greene MI, Tone M. 2008. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat Immunol 9: 194-202.
60. Tran DQ, Ramsey H, Shevach EM. 2007. Induction of FOXP3 expression in naive human CD4{thorn}FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood 110: 2983-2990.
61. Vahedi G, Takahashi H, Nakayamada S, Sun HW, Sartorelli V, Kanno Y, O'Shea JJ. 2012. STATs shape the active enhancer landscape of T cell populations. Cell 151: 981-993.
62. Vanvalkenburgh J, Albu DI, Bapanpally C, Casanova S, Califano D, Jones DM, Ignatowicz L, Kawamoto S, Fagarasan S, Jenkins NA, et al. 2011. Critical role of Bcl11b in suppressor function of T regulatory cells and prevention of inflammatory bowel disease. J Exp Med 208: 2069-2081.
63. von Boehmer H, Daniel C. 2013. Therapeutic opportunities for manipulating T(Reg) cells in autoimmunity and cancer. Nat Rev Drug Discov 12: 51-63.
64. Wang J, Ioan-Facsinay A, van der Voort EI, Huizinga TW, Toes RE. 2007. Transient expression of FOXP3 in human activated nonregulatory CD4{thorn} T cells. Eur J Immunol 37: 129-138.
65. Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, Buist N, Levy-Lahad E, Mazzella M, Goulet O, Perroni L, et al. 2001. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 27: 18-20.
66. Williams LM, Rudensky AY. 2007. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat Immunol 8: 277-284.
67. Xu L, Kitani A, Stuelten C, McGrady G, Fuss I, Strober W. 2010. Positive and negative transcriptional regulation of the Foxp3 gene is mediated by access and binding of the Smad3 protein to enhancer I. Immunity 33: 313-325.
68. Zheng Y, Josefowicz SZ, Kas A, Chu TT, Gavin MA, Rudensky AY. 2007. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 445: 936-940.
69. Zheng Y, Josefowicz S, Chaudhry A, Peng XP, Forbush K, Rudensky AY. 2010. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 463: 808-812.